Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Resmed Inc (RMD)

Resmed Inc (RMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,409,628
  • Shares Outstanding, K 146,425
  • Annual Sales, $ 3,578 M
  • Annual Income, $ 779,440 K
  • 60-Month Beta 0.50
  • Price/Sales 8.74
  • Price/Cash Flow 29.92
  • Price/Book 9.30
Trade RMD with:

Options Overview Details

View History
  • Implied Volatility 34.88% ( +2.65%)
  • Historical Volatility 25.88%
  • IV Percentile 63%
  • IV Rank 45.64%
  • IV High 50.55% on 04/27/22
  • IV Low 21.73% on 11/18/21
  • Put/Call Vol Ratio 0.75
  • Today's Volume 28
  • Volume Avg (30-Day) 168
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 4,297
  • Open Int (30-Day) 4,419

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 1.52
  • Number of Estimates 4
  • High Estimate 1.57
  • Low Estimate 1.46
  • Prior Year 1.51
  • Growth Rate Est. (year over year) +0.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
210.52 +1.89%
on 09/23/22
239.10 -10.28%
on 09/12/22
-10.17 (-4.53%)
since 08/23/22
3-Month
208.20 +3.03%
on 06/24/22
247.65 -13.38%
on 08/11/22
+7.02 (+3.38%)
since 06/23/22
52-Week
189.40 +13.26%
on 05/12/22
280.48 -23.52%
on 09/24/21
-68.24 (-24.13%)
since 09/23/21

Most Recent Stories

More News
Reasons Why You Should Retain ResMed (RMD) Stock For Now

Investors are optimistic about ResMed's (RMD) better-than-expected results and robust device sales.

MCK : 343.27 (-1.06%)
RMD : 214.51 (+0.38%)
PDCO : 25.28 (-0.86%)
AMN : 103.95 (-0.15%)
ResMed (RMD) Q4 Earnings Beat Estimates, Gross Margin Up

ResMed (RMD) posts better-than-expected Q4 results with continued strength in sleep and respiratory care devices sales performance.

MRK : 86.78 (-0.83%)
DGX : 122.35 (-0.40%)
MOH : 328.74 (-0.23%)
RMD : 214.51 (+0.38%)
ResMed (RMD) Q4 2022 Earnings Call Transcript

RMD earnings call for the period ending June 30, 2022.

RMD.AX : 33.000 (+3.00%)
RMD : 214.51 (+0.38%)
ResMed (RMD) Q4 Earnings Beat Estimates

ResMed (RMD) delivered earnings and revenue surprises of 0.68% and 0.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

RMD : 214.51 (+0.38%)
VRNOF : 4.9800 (-1.97%)
ResMed Q4 Preview: Rebound Quarter Inbound?

RMD has primarily exceeded the Zacks Consensus EPS Estimate. However, the company registered an 8% bottom-line miss in its latest quarter.

RMD : 214.51 (+0.38%)
Nephros Inc. (NEPH) Reports Q2 Loss, Tops Revenue Estimates

Nephros Inc. (NEPH) delivered earnings and revenue surprises of 14.29% and 6.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NEPH : 0.9720 (-0.31%)
RMD : 214.51 (+0.38%)
Light Week for Economic News

Monday U.S. Featured Earnings Dominion Energy (NYSE: D) (Q2) EPS projects for 77 cents, ...

D : 77.75 (-0.88%)
AIG : 49.77 (-2.81%)
BNTX : 128.35 (-1.27%)
EMR : 73.84 (-2.24%)
SYY : 74.92 (-3.18%)
WELL : 66.71 (-2.26%)
DIS : 99.50 (-2.60%)
CPNG : 16.08 (-4.00%)
FOXA : 31.71 (-1.25%)
BIDU : 118.75 (-0.06%)
RMD : 214.51 (+0.38%)
ILMN : 190.38 (-1.61%)
NuVasive (NUVA) Lags Q2 Earnings Estimates

NuVasive (NUVA) delivered earnings and revenue surprises of -14.55% and 1.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NUVA : 43.62 (-0.71%)
RMD : 214.51 (+0.38%)
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio

Acquisition lays foundation to build ResMed’s digital sleep medicine portfolio in Germanysomnio digital health application focused on improving sleep in...

RMD : 214.51 (+0.38%)
RMD.AX : 33.000 (+3.00%)
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022

SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the...

RMD : 214.51 (+0.38%)
RMD.AX : 33.000 (+3.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 220.17
2nd Resistance Point 217.45
1st Resistance Point 215.98
Last Price 214.51
1st Support Level 211.78
2nd Support Level 209.06
3rd Support Level 207.59

See More

52-Week High 280.48
Fibonacci 61.8% 245.69
Fibonacci 50% 234.94
Fibonacci 38.2% 224.19
Last Price 214.51
52-Week Low 189.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar